ESMO 2024 Insights: Pembro + CAPOX + Bevacizumab in MSS mCRC With High Immune Infiltrate - FFCD 1703 POCHI Trial | VuMedi

Find latest Colon Cancer videos · 300+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Pembro + CAPOX + Bevacizumab in MSS mCRC With High Immune Infiltrate - FFCD 1703 POCHI Trial

By 2024 ESMO Annual Meeting Insights Hub FEATURING David Tougeron

By 2024 ESMO Annual Meeting Insights Hub FEATURING David Tougeron

92 views

September 27, 2024

Comments 0

Login to view comments. Click here to Login